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ABSTRACT
An Evidence-Based Approach to Understanding and Treating
Electronic Cigarette Use in the Adolescent Population
Adelaide Laurel Amini
College of Nursing, BYU
Master of Science
Electronic cigarette (e-cigarette) use is popular among adolescents and leads to high
levels of nicotine exposure in this population. E-cigarette use by teenagers can lead to
development of nicotine addiction, chronic lung disorders, and lifelong incidence of depression,
anxiety, and attention-deficit disorder. Thus, it is vital that nurse practitioners understand
electronic cigarette devices and their effects on adolescent health, as well as treatment guidelines
regarding nicotine dependence specific to e-cigarettes. An educational module detailing the
history of e-cigarettes, adolescent vulnerabilities, health effects of vaping, and treatment options,
was created and distributed among a sample of 12 nurse practitioners. The purpose of the
module is to increase nurse practitioners’ understanding of teenage e-cigarette use.
Understanding was assessed before and after viewing the module, using a paired t-test. The
results showed a significant increase in participants’ knowledge of e-cigarettes after completing
the module, t(11)=5.4, p=0.001. Of the 12 participants, 83% indicated that their general
understanding of e-cigarette use in the adolescent population improved and 83% indicated that
their understanding of available treatment options for adolescent nicotine cessation improved.
This module will become available to nurse practitioners nationwide, via the American
Association of Nurse Practitioners online continuing education site, in order to further help
healthcare providers to gain a better understanding of e-cigarette use in the adolescent
population.
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An Evidence-Based Approach to Understanding and Treating
Electronic Cigarette Use in the Adolescent Population
Nicotine exposure among America’s youth has risen sharply over the past decade despite
the declining rates of youth who use cigarettes (Cullen et al., 2018). This dramatic increase in
adolescent nicotine use occurred as a result of the proliferation of electronic nicotine delivery
devices, called electronic cigarettes or e-cigarettes. More commonly referred to as vaping, this
new trend of e-cigarette use may soon result in a complete reversal of five decades of progress in
the reduction of teenage tobacco use. The surge in rates of vaping among adolescents caught
national attention in 2014 when e-cigarettes surpassed conventional cigarettes as the most
commonly used tobacco product among teenagers (U.S. Department of Health and Human
Services, 2016). Over the past five years, the number of high schoolers who use e-cigarettes has
more than doubled from 13.4% in 2014 to over 27% in 2019 (Cullen et al., 2018; Cullen et al.,
2019). Nurse practitioners who treat patients between the ages of 14 and 18 should understand
that at least one in four of their patients is likely involved in some degree of e-cigarette use.
Thus, it is imperative to understand e-cigarette devices, their effects on an adolescent’s health,
and treatment of patients who present with nicotine dependence specific to e-cigarettes.
E-cigarettes come in various forms, but most have a basic anatomy of a battery, an
atomizer, a liquid cartridge, and a mouthpiece. When the user inhales, the battery of the ecigarette heats the atomizer, which contains a metal coil. The coil then heats the liquid until it is
hot enough to be aerosolized into a breathable form. Many e-liquids contain high concentrations
of nicotine, and all e-liquids contain ingredients that are harmful to the lungs and other body
systems when inhaled (U.S. Department of Health and Human Services, 2016).
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Adolescents are particularly vulnerable to e-cigarette use for several reasons. Many are
drawn to the variety of e-liquid flavors and can acquire the devices easily through the internet or
from friends. Teens can use these devices discreetly, even at home or school, because many ecigarette models do not look or smell like conventional cigarettes. Other vulnerabilities include
low cost, peer pressure, targeted advertising by tobacco companies, misguided beliefs about
health effects, social media influence, and a lack of comprehensive U.S. Food and Drug
Administration (FDA) regulation. According to the U.S. Department of Health and Human
Services (2016), e-cigarettes are most widely used by teenagers and young adults aged 14-24,
even though these devices were originally designed as a smoking cessation aide for adults with
tobacco use disorders.
The drastic rise in adolescent e-cigarette use particularly concerns healthcare providers
because longitudinal studies have not been completed detailing the long-term health effects of
vaping on brain, heart, and lung function. However, a recent study completed by Yuan et al.
(2015) showed that inhaling high amounts of nicotine leads to significant cognitive impairment
in adolescents, including increased rates of depression, anxiety, impulsivity, and reduced
attention span.
Nurse practitioners must understand the nature of adolescent e-cigarette use to provide
patients and their parents with effective prevention and cessation strategies. In fact, pediatric
providers who are familiar with e-cigarette use in the adolescent population, and appropriate
interventional strategies, will address vaping with their patients more frequently, leading to lower
rates of initiation (Pepper, Gilkey, & Brewer, 2015).
One strategy for providing this timely information to practitioners is through the use of
internet-based, electronic learning modules. Online training modules are a form of e-learning
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that has been shown to be an effective educational tool (Mousazadeh et al., 2016). Thus, the
purpose of this project is to provide a 60-minute online module detailing the existing guidelines
for the prevention and treatment of adolescents involved in e-cigarette use. The information
contained in this module will describe the current status of vaping in the adolescent population,
highlight the specific vulnerabilities and health implications unique to youth, and provide
evidence-based information regarding prevention and intervention strategies specifically focused
on young e-cigarette users. The module is designed for Nurse Practitioners who work with
adolescents. The module will be reviewed and tested by a minimum of twelve nurse practitioner
experts. The experts will complete a survey about e-cigarette use in the teenage population
before and after viewing the module.
Literature Review
Background
In 2003, a pharmacist named Hon Lik invented the first commercially available ecigarette in Beijing, China (National Academies of Sciences, Engineering, and Medicine et al.,
2018). The original purpose of the e-cigarette was to function as an alternative to traditional
tobacco cessation products. Since entering the United States market in 2006, e-cigarettes have
become popular among all age groups, but especially middle and high school students. For
example, in 2015, only 3.5% of U.S. adults admitted to e-cigarette use compared with 5.5% of
middle schoolers and 15.5% of high school students (Jamal et al., 2017; U.S. Department of
Health and Human Services, 2016). E-cigarettes have been the most popular tobacco product
used by teens since 2014, and the reported number of teens experimenting with use continues to
rise yearly. In 2018, 3.6 million high schoolers reported current use of e-cigarettes, leading the
Surgeon General to declare it an epidemic for American adolescents (Cullen et al., 2018).
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The first type of e-cigarettes to be sold in the U.S. were “cig-a-likes” built to look and
feel like a conventional cigarette but free of many of the traditional toxins and carcinogens found
in cigarette smoke. These first-generation e-cigarettes are composed of a battery, an atomizer, a
heating coil, a cartridge to hold liquid, and a mouthpiece. When a user inhales or manually
presses a button, the battery powers the heating coil, which, combined with the atomizer, heats
the liquid inside the cartridge to a high temperature, where it is then aerosolized and can be
inhaled (Kaisar et al., 2016; Offermann, 2015).
Second-generation e-cigarettes, or vape pens, are similar to first-generation models in
anatomy but have a few different features, including a clear chamber that can hold more liquid
and a longer, narrower body, resembling a pen. Vape pens also allow the user to customize the
power, frequency, and length of puffs. Third generation e-cigarettes, personalized vaporizers, or
MODs differ greatly from the previous models as they are quite a bit larger and usually
rectangular shaped. These devices have complex designs that allow users to modify components
including wattage, voltage, and temperature (Rigotti & Kalkhoran, 2019).
In 2015, a new model of electronic nicotine delivery system (ENDS) was developed and
introduced to the market called a “pod mod.” The first company to market these products was
JUUL laboratories, but many other brands of pod mods have been developed since 2015. JUUL
products were originally designed to look small and thin like a USB flash drive. Because of their
inconspicuous appearance and different flavor options, these types of e-cigarettes became very
popular among youth users, attributing greatly to the drastic increase of high school student ecigarette use.
JUUL products are very different from traditional ENDS devices, both in shape and type
of nicotine used. It is important to note that the e-liquid used in JUUL products always contains
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nicotine. JUUL cartridges, called JUUL pods, contain nicotine salts derived from tobacco leaves
rather than the freebase nicotine contained in typical e-liquid formulations, allowing the user to
obtain a higher amount of nicotine per puff than most ENDS products (Willett et al., 2018). One
5% nicotine by weight (NBW) pod is akin to 200 puffs on a conventional cigarette and yields
59mg of nicotine per milliliter, which is as much nicotine as is contained in an entire pack of
cigarettes (United States Food and Drug Administration, 2018).
The liquids used in e-cigarettes (called e-liquids, vape juice, or smoke juice) are
composed of four main ingredients: water, flavoring, nicotine, and humectants. The humectants,
usually substances like propylene glycol and glycerin, liquefy the other ingredients, allowing the
e-liquid to transform into an aerosol when heated to a specific temperature (National Academies
of Sciences, Engineering, and Medicine et al., 2018). Although some e-liquids do not contain
nicotine, 99% include it in some amount (Marynak et al., 2017). E-liquids are commonly sold by
nicotine concentration: zero (0mg/ml of nicotine), low (6-12mg/ml), medium (18mg/ml) and
high (24mg/ml) (Kaisar et al., 2016). Many teens and adults report vaping with a liquid that
contains 0mg/ml of nicotine according to the label. However, there are blatant inconsistencies
with measured nicotine concentrations and their labeled amounts (Cheng, 2014; Hyman &
Brown, 2017; Kaisar et al., 2016; National Academies of Sciences, Engineering, and Medicine et
al., 2018; Rigotti & Kalkhoran, 2019). One study found between 5.7mg/ml to 23.9mg/ml of
nicotine in multiple flavor samples from various companies that were all labeled as 0mg of
nicotine (Raymond et al., 2018), and similar inconsistencies have been reported in other studies.
Adolescent Vulnerabilities with E-cigarettes
Recent studies have highlighted many vulnerabilities specific to the adolescent
population. To teenagers, one of the most attractive features of vaping is the multitude of
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flavors. Some of the most popular flavors include strawberry watermelon, blue raspberry, and
pink lemonade, but flavors can be as diverse as crème brûlée, nacho cheese, and dill pickle. In a
Texas study of over 15,000 e-cigarette users, 98% of teens reported that the first e-liquid they
tried was flavored to taste like “something other than tobacco.” Most adult e-cigarette users,
however, reported that they prefer flavors similar to conventional cigarettes (Harrell et al., 2016).
Adolescents often do not understand that fruity flavors have just as much nicotine and toxic
components as tobacco or menthol-flavored liquids.
With approximately 15,000 flavors of e-liquid available for purchase, it is not surprising
that one frequently cited reason that teens try vaping is that they are curious (Walley et al., 2019).
In fact, 57.1% of students cited curiosity as a major reason they began vaping (Bold et al., 2016;
Margolis et al., 2016). In a 2018 study, 25% of youth that had never before smoked a tobacco
product reported that they were curious about e-cigarettes and open to trying them (Margolis et
al., 2018). The internet is a pervasive source of promotional information regarding e-cigarette
use. For example, people who actively vape can influence others by posting positive stories
about their e-cigarette use and adding pictures or videos to social media platforms. Research has
established a connection between viewing positive vaping themes on social media and
subsequent e-cigarette initiation and use (Pokhrel et al., 2018). Other teens are attracted to using
e-cigarettes for sports like cloud chasing, where participants use the smoke generated from the ecigarette to make shapes and do tricks. In a study of 1,700 adolescents who use vaping devices,
74% reported watching vape tricks online, and 77.8% reported trying to mimic these tricks at
home (Pepper et al., 2017).
Peer influence, both through social media and with friends at school, is another
significant reason for youth e-cigarette initiation and continued use (Alberta Health Services,
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2014; Cavallo et al., 2019; Hwang & Park, 2016; Pokhrel et al., 2018). Bold et al. (2016) found
that 32.6% of teens stated that a major reason they began vaping was due to peer influence.
Adolescents have also cited that they are attracted to the ability to hide or disguise certain vaping
devices such as the original JUUL device, which can be easily concealed from parents and
teachers because of its unassuming appearance. Ramamurthi et al. (2018) searched YouTube for
videos related to adolescents’ methods for concealing e-cigarette usage, also known as “stealth
vaping,” and found 18,200 videos detailing how to vape in areas such as school and home
without being caught. Specific products have been designed with discretion in mind such as low
vapor visibility and low odor e-liquids. Some vaping devices are modeled to look strikingly
similar to typical belongings such as coffee mugs, ballpoint pens, cell phones, key fobs, inhalers,
boxes of Tic-tac’s, and hoodie drawstrings (Ramamurthi et al., 2018).
Furthermore, teens have easy access to e-cigarette products using the internet. One study
tested ease of acquisition by observing adolescent subjects attempt to purchase e-cigarettes from
various online vendors. Of these 98 vendors, only five invoked a firm age restriction, resulting
in a youth purchase rate of 93.7% (Williams, Derrick, & Ribisl, 2015). Since the FDA ruling in
2016, large companies have been forced to enforce age restrictions with internet sales. However,
few of these restrictions exist on smaller retailer sites, allowing for relatively easy purchasing by
minors (Chadi, Hadland, & Harris, 2019). Adolescents can also acquire e-cigarettes from
friends, family members, or young adult contacts who buy e-cigarettes in bulk and sell them to
minors for a profit. Of 3,614 high schoolers in a 2015 study, nearly half said they acquired their
e-cigarettes from a friend (Krishnan-Sarin et al., 2015).
Low cost is another factor in teenage e-cigarette use. When compared with traditional
cigarettes, e-cigarettes are much cheaper to use in the long run despite the moderately high start-
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up cost. For example, a JUUL starter pack that includes the reusable device and four pods costs
around $50, and the subsequent four-packs cost $16.99 each (Marcellin, 2019). One JUUL pod
yields about 200 puffs, which, according to JUUL’s website, is akin to a 20 pack of cigarettes,
which retails between $5-10/pack.
Health Implications of E-cigarette use in Adolescents
An additional risk factor for youth e-cigarette use is the classic behavioral changes
associated with adolescence that include increased risk-taking behavior (Yuan et al., 2015).
These patterns of impulsive and risky behaviors can be partially attributed to the fact that the
adolescent brain is actively maturing, creating additional synapses in the pathways responsible
for cognitive development and emotion regulation. The human brain has reached its optimal
mass by the age of 11 for girls and 14 for boys but continues development until the mid-30s
(England et al., 2017). However, not all brain lobes mature at the same rate. According to Yuan,
Cross, Loughlin & Leslie (2015), the emotional regions of the brain tend to mature more quickly
than the decision-making and impulse control systems, leading to more emotionally based
decisions associated with thrill-seeking behaviors. The limbic system, which specifically
controls cognition, emotion, and the drug reward pathway, is actively maturing during
adolescence. Conversely, the pre-frontal cortex, responsible for planning, processing
information, and impulse control, does not fully mature until well into the second decade of life
(England et al., 2017).
An adolescent’s brain is in a critical stage of development and has much greater plasticity
than an adult’s brain because it is actively creating new synapses based on input from current life
experiences. The brain uses these unique experiences to drive developmental pathways,
especially regarding dopamine, the neurotransmitter primarily involved in feelings of pleasure
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and reward in the brain. Dopamine is the main neurotransmitter involved in nicotine addiction.
After nicotine is absorbed and enters the bloodstream, it exerts its effects on the brain using
nicotinic acetylcholine receptors. The receptors accept the nicotine and initiate dopamine
neurotransmitter release. Dopamine release also affects other neurotransmitters, increasing
glutamate, and decreasing GABA, which both indirectly raise dopamine levels (U.S. Department
of Health and Human Services, 2014).
Administering a drug like nicotine to a developing brain can manually rewire brain
processes to adapt to the unnaturally high levels of dopamine that cause addiction and the low
dopamine levels that remain after nicotine concentrations have tapered off, causing withdrawal.
The normalization of the sharp contrasts between high and low levels of dopamine can cause a
lifelong dopamine imbalance in the brain, potentiating or even causing depression, anxiety,
attention deficit disorders, and impulsivity when these co-morbidities may not have developed
had the brain never been exposed to nicotine. Furthermore, the ventral tegmental area in the
adolescent brain, responsible for the reward system and addiction potential, is more sensitive to
nicotine addiction than the adult brain. As a result, those who start vaping as teenagers are more
likely to become lifetime smokers and have a harder time reversing the addiction than those who
start as adults. England et al. (2017) states that since adults are past this critical developmental
stage, fully matured adult brains do not have as much affinity to nicotine and are therefore less
susceptible to addiction than adolescent brains.
In a study by Yuan, Cross, Loughlin & Leslie (2015), rats were used to model the
difference between adolescent and adult nicotine-induced behavioral characteristics. Adolescent,
but not adult, aged rats were shown to have increased impulsivity, anxiety, depression, and fear
when chronically exposed to nicotine, as well as decreased cognitive abilities and attention span.
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Another study showed that adolescent aged rodents exposed to consistent amounts of cigarette
smoke demonstrated cognitive impairments that included reduced working memory, spatial
memory, and auditory processing, as well as weakened executive planning irrespective of the last
exposure (England et al., 2017).
Natural, non-drug reward pathways are also compromised in teenagers who use nicotine
regularly, leading to significant struggles with cessation and an affinity for alternate drugs such
as conventional cigarettes, marijuana, cocaine, methamphetamine, and alcohol (Curran et al.,
2018; U.S. Department of Health and Human Services, 2016). One study cited that a third of
adolescents who vape have also reported using an e-cigarette to smoke marijuana (Chadi et al.,
2019). Additionally, various studies have concluded that e-cigarette use does lead to the use of
combustible cigarettes (King et al., 2015; Pènzes et al., 2018; Primack et al., 2015; Rigotti &
Kalkhoran, 2019; Walley et al., 2019).
Nicotine Dependent Health Effects of Vaping
Historically, nicotine has been classified as a substance that is addictive but does not
adversely affect other organ systems, but this theory has since been proven false. Inhaled
nicotine is rapidly absorbed and has sympathomimetic effects on the human body, causing
increased heart rate and blood pressure and promoting systemic vasoconstriction, which can
cause endothelial damage. Inflammation in the vascular tissue results in atherosclerotic plaque
formation and platelet aggregation, the combination of which can produce a myocardial
infarction or cerebrovascular accident. Nicotine use can also contribute to cardiac remodeling,
leading to an increased risk of heart failure and sudden cardiac death. Frequent use of nicotine is
associated with the development of hypertension, diabetes mellitus, dyslipidemia, and
thrombogenesis (Benowitz & Burbank, 2016). Furthermore, it is hypothesized that nicotine can
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affect the blood-brain barrier of the brain, thus increasing the risk of developing various
neurodegenerative diseases in the future. Nicotine is also known to decrease systemic immune
responses and increase systemic inflammation, leading to delayed wound healing, especially in
areas of the mouth and gums where burns from vaping are common (Lei et al., 2017).
E-cigarettes can potentially deliver a much higher dose of nicotine into the bloodstream
than a combustible cigarette. An average combustible cigarette contains between 10 and 15
milligrams of nicotine yet will only deliver about one milligram into the bloodstream (Bhatnagar
et al., 2014). In contrast, an e-cigarette can deliver between a third to a fourth of its nicotine
concentration into the systemic circulation, meaning that an e-liquid with a 24mg/ml
concentration will deliver between six and eight milligrams of nicotine per milliliter of e-liquid
into the systemic circulation when inhaled (Kaisar et al., 2016).
Lastly, multiple studies have demonstrated that adolescents who vape experience ecigarette specific withdrawal symptoms, including difficulty concentrating, irritability,
nervousness, restlessness or anxiety, and a strong urge to vape (Case et al., 2018; Pbert et al.,
2015). Other withdrawal symptoms may include headaches, sleeping difficulty, and increased
appetite (Chadi et al., 2019).
Non-Nicotine Dependent Health Effects of Vaping
E-cigarettes possess multiple health risks independent of the harms of nicotine. Although
manufacturers have recently been forced to display nicotine-warning signs on the front of ecigarette and e-liquid packaging, detailed ingredient lists are rarely included. Many of the
chemicals contained in e-liquids are harmful when inhaled. The solvents propylene glycol and
glycerol contained in most e-liquids have been labeled “GRAS” by the FDA but have only been
approved for oral consumption in specific amounts and not for inhalation (Kaisar et al., 2016).
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The flavorings in e-liquids are also far from benign. A 2015 study found that over threefourths of 159 different sweet or creamy tasting e-liquids contained the flavoring chemicals
diacetyl or acetyl propionyl, which have been known to cause a fixed obstructive lung disease
called bronchiolitis obliterans when inhaled (Center for Disease Control and Prevention, 2002;
Marcellin, 2019; National Academies of Sciences, Engineering, and Medicine et al., 2018).
Bronchiolitis obliterans involves inflammation of the bronchioles, which can lead to scarring and
respiratory compromise. This disease was nicknamed “popcorn lung” in the year 2000 after
several employees in a microwave popcorn factory contracted a severe respiratory illness from
inhaling the butter flavor fumes. Other studies have found that exposure to these chemicals can
also cause asthma, bronchitis, and pulmonary fibrosis (Marcellin, 2019).
As of February 2020, there have been 2,807 cases of e-cigarette or vaping associated lung
injuries (EVALI) and 68 vaping-related deaths reported to the Centers for Disease Control and
Prevention (CDC) (Centers for Disease Control and Prevention, 2019a). While there is not one
specific compound responsible for all cases of EVALI, a strong correlation exists between
patients who have recently used e-liquids that contain tetrahydrocannabinol (THC) and increased
incidence of EVALI. Bronchoalveolar lavage samples of affected patients have identified
vitamin e acetate as the primary offending agent in EVALI cases. Vitamin E acetate is
commonly mixed with THC containing e-liquids as a thickening agent (Jatlaoui et al., 2019).
Although vitamin E acetate is found in the lungs of most patients with EVALI, the FDA is still
unsure of what other compounds could be contributing to the illnesses. Thus, the FDA and CDC
both strongly advise against the use of any e-cigarette product until all causes of EVALI can be
identified. Prior to hospitalization, many patients suffering from vaping-related respiratory
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illnesses reported symptoms of dyspnea, shortness of breath, chest pain, as well as vomiting,
diarrhea, fever, and fatigue (Sharpless, 2019).
Incidences of other dangerous lung conditions associated with vaping are also on the rise.
One of these illnesses, lipoid pneumonia, has been reported in numerous cases across the U.S.
Researchers have cited the oil-based glycerol contained in e-liquids as the primary cause, which,
when inhaled, results in respiratory distress and some instances of respiratory failure (Itoh et al.,
2017; Viswam et al., 2018).
Other e-liquid flavoring components have also been proven harmful when inhaled. For
example, menthol and ethyl maltol, commonly found in e-liquids, are chemicals known to have
cytotoxic properties (Omaiye et al., 2019). A study that detailed the chemical composition of eliquid flavors found that many contained 30 and 100 times the cytotoxic level of menthol and
ethyl maltol, respectively. Cinnamaldehyde is another commonly used flavoring agent in sweet
and cinnamon flavors of e-liquid that is known to directly cause DNA strand destruction,
resulting in cell death when inhaled (Kaisar et al., 2016; National Academies of Sciences,
Engineering, and Medicine et al., 2018; Rigotti & Kalkhoran, 2019).
Carcinogens such as formaldehyde and benzaldehyde can be created during the heating
process of vaping and have been detected in high amounts in e-cigarette vapor (Goniewicz et al.,
2014; Kaisar et al., 2016; National Academies of Sciences, Engineering, and Medicine et al.,
2018; Offermann, 2015; Rigotti & Kalkhoran, 2019; U.S. Department of Health and Human
Services, 2016). The magnitude of voltage used to heat the liquid directly affects how much
aldehyde is formed while vaping. Kosmider et al. (2014) found that increasing the voltage in an
e-cigarette from 3.2 volts to 4.8 volts resulted in the formation of 4-200 times the amount of
carcinogenic compounds (formaldehyde, benzaldehyde, and acetone) yielded.
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Twenty-six percent of teens who vape admit to manually dropping e-liquid directly on a
heating coil and then immediately inhaling the aerosol, a process known as “dripping.” Dripping
exposes teens to exponentially higher amounts of carcinogenic byproducts due to the higher
aerosolization temperatures and is also dangerous because it involves close proximity with an
extremely hot liquid that can result in burns (Krishnan-Sarin et al., 2017; Talih et al., 2016).
Furthermore, researchers have identified multiple heavy metals in e-cigarette aerosol and
found that the metals are created during the reaction between the metal heating coil and e-liquid
inside the heating chamber. This reaction results in the formation of cadmium, chromium,
copper, nickel, lead, tin, manganese, arsenic, and zinc, which are toxic to the human body when
inhaled (Goniewicz et al., 2014; Hess et al., 2017; National Academies of Sciences, Engineering,
and Medicine et al., 2018; Offermann, 2015; Olmedo et al., 2018; Rigotti & Kalkhoran, 2019;
U.S. Department of Health and Human Services, 2016). Heavy metals are more readily absorbed
when inhaled than when ingested and can lead to neurotoxicity, cardiovascular disease, and lung
cancer (Marcellin, 2019). Other toxic volatile organic chemicals such as acrylonitrile, propylene
oxide, acrylamide, and crotonaldehyde have been found in the urine of adolescent e-cigarette
users in much higher quantities than those that do not use e-cigarettes (Rubinstein et al., 2018).
Vaping also induces oxidative stress and inflammation throughout the lung tissue,
decreasing forced expiratory volume, and causing greater amounts of nitric oxide to be retained
during expiration (Eltorai, Choi, & Eltorai, 2019). It has been shown that smoking e-cigarettes
can damage heart tissue leading to increased prevalence and severity of cardiac defects.
Immunologically, e-cigarettes can cause increased inflammation and decreased neutrophil and
macrophage efficiency, leading to greater cell death in alveolar cells and decreased immunity to
viral and bacterial pathogens (Eltorai, Choi, & Eltorai, 2019).
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E-cigarettes have also been known to explode, causing mild to severe injuries. In 2016,
1,007 patients were treated in the U.S. for burns related to e-cigarette explosions. The most
common injuries were second or third-degree burns on the face, hands, thighs, and genitals. The
explosions have also resulted in lacerations, broken necks, and shattered teeth. The first death
from an e-cigarette explosion occurred in 2018 when the brain was hit by shrapnel from the blast
(Seitz & Kabir, 2018).
The dangers of vaping also extend to accidental nicotine poisonings. The densely
concentrated amount of nicotine present in e-liquid is made to be rapidly absorbed. Accidental
spills on the skin have been reported, resulting in nicotine poisoning of differing degrees of
severity in both adults and children. Symptoms of nicotine poisoning include nausea, vomiting,
diarrhea, increased salivation, and respiratory secretions, bradycardia, seizures, respiratory
depression, coma, and cardiac arrest (National Academies of Sciences, Engineering, and
Medicine et al., 2018). Since 2013, over 20,000 calls have been made to the National Poison
Data System (NPDS) regarding liquid nicotine exposures, thousands of which were exposures in
children under the age of six who had either touched or swallowed e-liquid (American
Association of Poison Control Centers, 2017; Govindarajan et al., 2018). In one case, a 15month old child died after ingesting five milliliters of an e-liquid with a 10mg/mL concentration
(Seo et al., 2016).
Because e-cigarettes are a relatively new product, there are no longitudinal studies
available that detail the health effects of e-cigarettes in humans and specifically adolescents.
With the limited available models and studies, it can be concluded that nicotine-containing ecigarettes are addictive and potentiate neurologic and cognitive disorders in children and
teenagers (U.S. Department of Health and Human Services, 2016). Thus, it is vitally important
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for government regulatory bodies to act quickly to prevent injury and death related to e-cigarettes
and e-liquids in children and adolescents.
Policy
In the past, government entities have been slow to regulate tobacco products and
marketing. For example, it became public knowledge that smoking causes lung cancer over 50
years ago. However, it was not until 2009 that Congress established the Family Smoking
Prevention and Control Act, which gave the FDA license to regulate the manufacturing,
distribution, and marketing of tobacco products (U.S. Department of Health and Human
Services, 2016). At that time, e-cigarettes were not legally considered “tobacco products”
because they contain only nicotine and not whole leaf tobacco. Because of this legality, ecigarettes were left practically free from regulation for the next seven years, during which time,
the market for e-cigarettes grew exponentially. The FDA repeatedly attempted to restrict sales of
vaping products but were unsuccessful because e-cigarettes needed to be officially designated as
a tobacco product before they could be subject to FDA regulation. In 2016, the “Deeming Rule,”
was passed which expanded the FDA’s regulatory authority to incorporate e-cigarettes and eliquids into the original law (United States Food and Drug Administration, 2016). The Deeming
Rule prohibits sales of e-cigarette products to consumers under the age of 18 and the use of free
samples to promote sales. It also restricts e-cigarettes from being sold in vending machines in
areas where minors are present and requires mandatory warning labels to be placed on nicotinecontaining products. Furthermore, the new law requires e-cigarette manufacturers and
distributors to receive marketing authorization from the FDA and mandates compliance with
established legal requirements of tobacco manufacturers (United States Food and Drug
Administration, 2017).
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As a part of the Deeming Rule, the FDA required e-cigarette manufacturers to disclose
ingredient lists and documents on known health effects of their products, thus subjecting all
products to pre-market review and proof of public health benefit (U.S. Department of Health and
Human Services, 2016). This new regulation met major resistance from large tobacco
companies and pro-vaping groups. These groups insisted e-cigarettes remain free from heavy
regulation because of their potential to help adult smokers quit smoking, a claim that is
passionately debated in current literature.
In response, the FDA extended the 2018 deadline of the Deeming Rule to the year 2022.
This four-year extension was legally challenged by a team of public health authorities including
the Campaign for Tobacco-Free Kids, the American Heart Association, the American Lung
Association, the American Academy of Pediatrics, American Cancer Society Cancer Action
Network, Truth Initiative, and five individual pediatricians because delayed action would worsen
the teenage vaping epidemic (American Academy of Pediatrics, et al. v. United States Food and
Drug Administration, et al., 2019; Jenssen et al., 2019). In July 2019, the public health
organizations won the lawsuit filed against the FDA, which overruled the extended deadline. As
a result of the legal decision, all e-cigarette products are now subject to premarket review, and
manufacturers are legally required to submit products and ingredient lists for public health
evaluation by May of 2020 or their products will be pulled from the market (American Heart
Association, 2019).
Prevention Strategies
Parental Prevention
Studies have shown that parental intervention is a significant factor in youth tobacco
prevention (Thomas, Baker, & Thomas, 2016). Specific parenting strategies found to be
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effective are setting limits, communicating openly with children about substance abuse, and
assisting children with developing social skills to resist peer pressure. Tobacco prevention
interventions were found to be much more effective when taught in the home and at school,
rather than only in school settings. Multiple resources exist for parents to become acquainted
with e-cigarettes and how to talk with children about vaping. These include information sheets
and websites created by the CDC, the American Lung Association, the Surgeon General, the
Campaign for Tobacco-Free Kids, Partnership for Drug-Free Kids, Tobacco Free California, and
the American Academy of Pediatrics (American Academy of Pediatrics, 2019a; American Lung
Association, 2019; California Tobacco Control Program, 2019; Centers for Disease Control and
Prevention, 2019b; Centers for Disease Control and Prevention, 2019c; Partnership for DrugFree Kids, 2019; Tobacco Free California, 2019).
School and Community Prevention
School-based interventions have also been shown to be effective at short-term tobacco
prevention and, in one systematic review, were shown to have decreased youth intention to
smoke by 12% (Das et al., 2016; Duncan et al., 2018; Rigotti & Kalkhoran, 2019; Towns et al.,
2017). Studies show that the most effective programs for youth focus on building social skills,
problem-solving, and resisting peer pressure. Resources for use in school and community
settings include toolboxes and presentations specifically created for youth education, including
the Not On Tobacco Program (NOT) supported by the American Lung Association (United
States Food and Drug Administration, 2018), the Stanford Medicine Tobacco Prevention Toolkit
(Stanford Medicine, 2019), the Make Smoking History toolkit (Massachusetts Tobacco Cessation
and Prevention Program, 2019), the CATCH My Breath E-cigarette prevention program (Catch
Global Foundation, 2019), the Minnesota toolkit (Minnesota Department of Health, 2019),
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SmokeSCREEN videogame for teacher implementation (Yale University, 2019), the Scholastic
Real Cost of Vaping Program (Scholastic, 2019), and the CDC’s Youth Guide to E-cigarettes
presentation (Centers for Disease Control and Prevention, 2019d). While not nearly as effective
as parental-based interventions, school, and community-based tobacco prevention programs are
moderately effective at preventing tobacco use in teens (Das et al., 2016; Thomas et al., 2016).
Healthcare Provider Intervention
Many studies have shown that practitioner-led interventions can be effective in
preventing and reducing youth tobacco use (Duncan et al., 2018; Farber et al., 2015; Hagan,
Shaw, & Duncan, 2008; Pbert et al., 2015; Thomas et al., 2016; Tobacco Use and Dependence
Guideline Panel, 2008). Healthcare providers have the opportunity to teach adolescents about
the negative health effects of e-cigarette use during a time and in a setting where receptivity may
be higher than at home or school. Healthcare providers are adolescents’ preferred source of
information regarding tobacco prevention and cessation (Pbert et al., 2015). Furthermore, the
perception of e-cigarettes as being addictive and harmful is a protective factor against youth ecigarette initiation (Kwon et al., 2018), and teenagers who are advised to quit by their healthcare
provider are more likely to do so. Effective strategies for prevention include practitioners
actively screening for e-cigarette use during patient visits, as well as providing information about
why vaping is harmful, and discussing strategies to avoid initiation (American Academy of
Pediatrics, 2015).
The 5 A’s
The American Academy of Pediatrics (AAP), as well as numerous other organizations
(Alberta Health Services, 2014; American Academy of Pediatrics, 2015), suggests using the “5
A’s” screening and intervention model (ask, advise, assess, assist, and arrange follow up)
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adapted from the U.S. Public Health Service Clinical Practice Guidelines to counsel with
pediatric patients about e-cigarette use (Farber et al., 2015; Tobacco Use and Dependence
Guideline Panel, 2008). The Bright Futures Guidelines inserts a precursory “A” which stands for
“anticipate” to the beginning of the model (Hagan et al., 2008). A practitioner should anticipate
that any patient could be exposed to, actively using, or be vulnerable to future use of any tobacco
product. Guidelines suggest interviewing the patient without the parent present in the room to
ensure privacy when discussing sensitive matters such as e-cigarette use.
1) Ask. First, it is strongly recommended that practitioners ask about all types of tobacco
smoke exposure with every patient. Bright Futures suggests that first asking about friends’ ecigarette use can help the patient feel more comfortable with being questioned about their use.
Examples of these questions include; “Do any of your friends use e-cigarettes, e-hookah, or
vape?” and “Have you tried an e-cigarette, e-hookah, or vape?” If the patient denies use, the
provider should give positive reinforcement but also take the opportunity to ask the patient why
he/she has chosen not to vape and discuss strategies to resist e-cigarette advertising and peer
pressure (Farber et al., 2015; Pbert et al., 2015; Tobacco Use and Dependence Guideline Panel,
2008).
2) Advise. Second, if the patient admits to past or current e-cigarette use, the practitioner
should strongly advise the patient to discontinue use and clearly explain the harms associated
with the beginning or continuing to vape. This interventional step should be a discussion rather
than a lecture and should be personalized to the needs of the patient. Experts have found that
adolescent tobacco users are often interested in quitting, especially when the practitioner uses
truths about e-cigarette prevention that pertain specifically to teenagers (Alberta Health Services,
2014; American Academy of Pediatrics, 2015). Messages that seem most effective for teens
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focus on the loss of independence that comes from addiction, the damaging effect of nicotine on
the developing brain, and that tobacco companies are manipulating teenagers into getting
addicted to nicotine to replace the dying smoker population. The AAP suggests the provider
empowers the patient by showing faith that the patient can quit, giving ample encouragement,
and offering to help the patient through the process (Pbert et al., 2015; Towns et al., 2017).
3) Assess. Third, the healthcare provider should assess the level of dependence
associated with the patient’s e-cigarette use to understand best how to help the patient quit.
Questions could include asking what products the patient uses, why he/she vapes, how often
he/she vapes, how long per session, if he/she has experienced withdrawal symptoms, how
quickly withdrawal symptoms appear after use, and if he/she has ever tried to quit previously.
The Modified Fagerstrom Tolerance Questionnaire, the “Hooked on Nicotine Checklist”
(HONC), and the Youth Multidimensional Dependence Assessment Tool are resources that
providers can use to assess their patient’s potential to become dependent on nicotine or active
level of nicotine dependence (Alberta Health Services, 2014; DiFranza et al., 2002; Towns et al.,
2017). No data were found that suggest one tool is more effective than another.
The practitioner should also assess the adolescent’s readiness to quit. Readiness to quit
can be measured by directly asking the patient how ready he/she is to quit, what barriers he/she
sees to quitting, how important it is for him/her to quit, and how confident he/she is in their
ability to quit (Pbert et al., 2015). A practitioner can also use the “Tobacco Use and Quitting
Self Evaluation Tool” to help the patient self-identify how ready they are to quit using ecigarettes (Optima Health, 2019). Furthermore, the practitioner must understand that e-cigarette
use may be a way that a teen has chosen to cope with an underlying disorder that needs to be
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treated. Thus, the provider must carefully assess for any signs of mental or physical health
conditions or a history of abuse (Farber et al., 2015; Hwang & Park, 2016).
4) Assist. Fourth, the practitioner should assist the patient in stopping the use of ecigarettes, or at least decrease e-cigarette use if the patient is unwilling to stop at this time.
Appropriate treatment for patients who use e-cigarettes includes working with the patient to set
specific goals customized to the patient’s readiness to quit.
Ready to quit. If the patient is ready to quit, the practitioner can set a quit date with the
patient and make a detailed plan, including the use of medications, if necessary (Alberta Health
Services, 2014). The clinician should ask the patient to detail barriers they see to quitting and
their specific triggers to vape. Also, clinicians should ask about the environment in which the
patient usually vapes, and other influences that reinforce the habit. Ask the patient to name the
things that weaken their desire to vape and a list of supportive and positive influences such as
exercise, friends, family, and other coping mechanisms. The provider should then help the
patient understand withdrawal symptoms and establish readily accessible resources for the
patient to use when withdrawals become hard to manage (Pbert et al., 2015). If the
parents/primary caregiver does not yet know about the patient’s e-cigarette use, offer to help the
patient tell them about the problem and the quit plan, thus allowing them to receive an optimum
level of support through the process.
Considering quitting. If the patient is considering quitting, the clinician can provide
positive reinforcement, and ask the patient to explain what is important to him/her about quitting.
The practitioner should also identify barriers and detail positive influences as well as give
additional benefits associated with quitting and discuss quitting resources available to the patient
when he/she feels ready. Lastly, help the patient make a small goal that he/she can begin
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working on immediately. An example would be keeping a tobacco use log that can help the
patient identify triggers and discover how their body responds to nicotine withdrawals, thus
helping him/her to gather information for a quit attempt in the future (University of California,
San Francisco, Schools of Pharmacy and Medicine, 2019a).
Not ready to quit. For teenage patients who are unwilling to quit, the AAP recommends
using a motivational counseling method called the “5R’s” which stands for relevance, risks,
rewards, roadblocks, and repetition (Farber et al., 2015; Pbert et al., 2015). a) Relevance:
Discuss with the patient why quitting would be important to him/her. b) Risks: Ask the patient
to talk about the risks and side effects associated with continuing to use e-cigarettes. c)
Rewards: Ask the patient to explain the benefits of quitting that would be important to him/her.
d) Roadblocks: Ask the patient about what barriers are preventing him/her from quitting. e)
Repetition: Repeat this method during each subsequent visit with the patient, helping the patient
to understand that it often takes many quit attempts before achieving success. The practitioner
can also provide the patient with information about the harms and dangers of vaping and the
rewards associated with cessation in a non-judgmental manner. Lastly, the practitioner should
help the patient understand that help is available to him/her as soon as he/she is ready to consider
quitting.
5) Adequate follow up. Fifth, for the patients who agree to treatment, the primary care
provider must ensure adequate follow up is provided. Well-organized follow-up with adolescent
patients has been shown to increase compliance with treatment plans and decrease the chances of
relapse (Farber et al., 2015; Pepper et al., 2015). To initiate this process, the provider can
discuss with the patient a method and a period of time to follow up on his/her progress. Current
guidelines suggest following up with patients who are attempting to quit at least once within the
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first week, and then a second time within the next month. For adolescent patients not willing to
quit, follow up can be provided at the next clinic visit.
If upon follow up, the provider discovers that the patient has relapsed and is continuing to
use e-cigarettes, a three-step protocol using an adjusted “AAR” method can also be used: 1) Ask
about the quit attempt, what treatments or coping strategies the patient had used, and how the
treatment worked for the patient. 2) Advise the patient to try again using a combination of
treatment options. 3) Refer the patient to a behavioral change program if he/she is not already
involved in one (University of California, San Francisco, Schools of Pharmacy and Medicine,
2019b).
Treatment
Reference guides and training programs exist that can help practitioners to learn tobacco
cessation strategies specific to the adolescent population. These include the 2008 Treating
Tobacco Use and Dependence: Clinical Practice Guideline (Tobacco Use and Dependence
Guideline Panel, 2008), the American Academy of Pediatrics reference documents (American
Academy of Pediatrics, 2015; American Academy of Pediatrics, 2019b), Tobacco Free Futures
Guidelines (Alberta Health Services, 2014), State-of-the-Art office-based interventions to
eliminate youth tobacco use: the past decade (Pbert et al., 2015), UpToDate (Rosen & Sockrider,
2019; Sockrider & Rosen, 2019), Optima health clinical guidelines for tobacco cessation and ecigarette use (Optima Health, 2019), the Rx for Change module training series (University of
California, San Francisco, Schools of Pharmacy and Medicine, 2019c), Kids Quit physician
training modules (The Children’s Hospital at Westmead, 2019), and Smokefree.gov resources for
physicians (National Institute of Health, 2019a).
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Published guidelines detailing the treatment of adolescent nicotine addiction suggest the
best approach is multifaceted and should include both behavioral and pharmacological
interventions. Unfortunately, published data on the effectiveness of behavioral or medicinal
treatments for e-cigarette use does not yet exist and no nicotine replacement therapies are FDA
approved for use in adolescent patients. Therefore, the current recommendation for treatment is
to refer to the provider’s discretion until more research can be done (Alberta Health Services,
2014).
Published guidelines suggest that when counseling a patient about his/her e-cigarette use,
two separate issues associated with nicotine dependence need to be addressed: the habitual
behavior of using the nicotine delivery device and the physiological dependence on nicotine
(University of California, San Francisco, Schools of Pharmacy and Medicine, 2019c). Thus,
both the behavioral and physiological needs of the patient should be addressed in treatment.
Behavioral Interventions
Counseling is the first-line treatment in adolescents who use tobacco products and has
been shown to double youth tobacco abstinence rates when compared with no intervention
(Tobacco Use and Dependence Guideline Panel, 2008). However, evidence has not yet
identified which aspect or form of counseling has the highest success rate (Peirson et al., 2016).
Because of this, the 2008 Treating Tobacco Use and Dependence: Clinical Practice Guideline,
AAP, Cochrane Database, and all existing practice guidelines suggest using a mixture of targeted
behavioral techniques for treatment of teens who use tobacco products. Studies have shown that
youth are 34% more likely to follow through with a quit attempt when clinicians used behavioral
interventions (Canadian Task Force on Preventive Health Care, 2017). Programs proven to help
with smoking cessation in adolescents included the use of social influence, positive media, anti-
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vaping peer pressure, cognitive-behavioral strategies, stress management techniques, and
motivational enhancement (Towns et al., 2017).
Furthermore, the 2008 Treating Tobacco Use and Dependence: Clinical Practice
Guideline states that adolescents treated with a combination of therapies, such as counseling with
a practitioner paired with motivational interviewing, interactive computer interventions, or
mobile-based interventions, are more likely to be successful in their quit attempt. Providers can
refer to counseling services for patients where more thorough counseling is needed, or for
specific treatments such as cognitive-based therapy (CBT) which is effective in treating teenage
e-cigarette use (Duncan et al., 2018; Harvey & Chadi, 2016; Simon et al., 2015). Coping or
distraction strategies suggested by various guidelines include the use of support groups, talk
therapy, guided imagery, positive self-talk, meaningful distractions, exercise, sports, hobbies,
calling a friend, deep breathing, yoga or mindfulness tactics to distract from cravings.
Internet and mobile-based intervention methods are becoming more popular as antivaping aids, but more research must be done before effectiveness can be documented (Alberta
Health Services, 2014). Computer and internet-based resources for e-cigarette cessation include
The Real Cost campaign (U.S. Department of Health and Human Services, 2019), Truth
Initiative (Truth Initiative, 2019), Smokefree Teen (National Institute of Health, 2019b), My Life
My Quit (National Jewish Health, 2019) and many others. One small pilot study showed that
videogames could be effective at increasing youth awareness of e-cigarettes and decreasing
initiation. A randomized control trial done in 2018 found that short-term exposure to a
videogame that challenged traditional beliefs and attitudes about e-cigarettes could aid in youth
vaping prevention by altering risk factors that ultimately lead to the initiation, such as lack of
knowledge about the health effects of vaping (O’Connor et al., 2019; Pentz et al., 2019).
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Another means to prevent teenage e-cigarette use is personalized mobile messages with antivaping themes. Studies have shown that at least 90% of teenagers own a mobile phone and most
cite text messaging as their preferred method of communication (Noar et al., 2019). Research
has shown that text messaging-based interventions are proven to help smokers with cessation
when compared with controls and may be effective with youth tobacco prevention and cessation
(Scott-Sheldon et al., 2016; Simon et al., 2015).
Pharmacological Interventions
To help a teenager to quit using e-cigarettes, the physiological addiction to nicotine may
need to be addressed and attenuated with nicotine replacement therapies. The 2008 Treating
Tobacco Use and Dependence: Clinical Practice Guideline states that although nicotine
replacement therapies (NRT) are not FDA approved for use in patients under 18, nicotine
replacement is safe in adolescents and may be effective in short-term abstinence (Tobacco Use
and Dependence Guideline Panel, 2008). Although nicotine in any form or amount is harmful to
adolescents, healthcare providers understand that if the patient is already absorbing high amounts
of nicotine via e-cigarette use, the patient can potentially decrease nicotine exposure and may be
able to stop vaping using NRT. Thus, multiple guidelines and studies conclude that
pharmacotherapy for adolescent e-cigarette cessation can be considered if there is evidence of
tobacco dependence and the patient has a desire to quit smoking (Alberta Health Services, 2014;
Myung et al., 2019; Pbert et al., 2015; Rosen & Sockrider, 2019; Siqueira & AAP COMMITTEE
ON SUBSTANCE USE AND PREVENTION, 2017; Tobacco Use and Dependence Guideline
Panel, 2008). However, healthcare providers must be diligent with follow up and monitor for
adverse effects or lack of compliance with treatment.
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Nicotine replacement therapies use a long-acting form of nicotine that is slowly absorbed
to attenuate the withdrawal symptoms associated with stopping tobacco use. These medications
have low abuse potential but can have side effects such as local skin or membrane irritation, and
increased heart rate and blood pressure. The dose, frequency, and length of nicotine replacement
treatment time should be titrated to the needs of the patient to reduce withdrawal symptoms to a
manageable level. Studies have shown that in adolescent patients, use of NRT can help with
short-term abstinence but does not significantly influence long-term cessation (Pbert et al.,
2015). The available forms of NRT include patches, gum, lozenges, nasal spray and inhalers.
For the adolescent patient, nicotine patches and gum are the most effective and well-tolerated
(Rosen & Sockrider, 2019). These products are available by prescription to patients under the
age of 18 and dosages can be titrated to the patient’s level of nicotine dependence.
Bupropion (Wellbutrin) is an antidepressant medication that acts on the dopamine and
norepinephrine neurotransmitters in the brain. It can be used to aid in several types of addictions
as it helps to stabilize dopamine levels in the brain. Although the results are mixed, some studies
do suggest that the use of bupropion for nicotine cessation can be effective in the short-term
(four weeks) treatment of adolescent smokers (Myung et al., 2019). However, bupropion was
not shown to be effective at maintaining abstinence from tobacco at 52 weeks. Clinicians should
be aware that bupropion also has potential side effects, including suicidal ideation, insomnia,
headache, agitation, tremors, tachycardia, diaphoresis, nausea and vomiting.
Varenicline (Chantix) is a partial nicotinic agonist that is used for tobacco cessation in
adults. In 2019, a randomized control trial involving adolescents found no significant evidence
that the use of varenicline contributed to tobacco cessation in youth aged 12-16 (United States
Food and Drug Administration, 2019). The common side effects of taking varenicline include
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headache, nausea, vomiting, constipation, irritability, suicidal ideation, depression, and sleep
disturbances. Reference guides such as UpToDate do not recommend varenicline as an
appropriate treatment for adolescents due to the severity of side effects and lack of efficacy in
documented clinical trials (Rosen & Sockrider, 2019).
Methods
Review of Literature
The literature review was utilized to create the education module. A comprehensive
literature review of scholarly articles regarding adolescent e-cigarette use was conducted. Data
for the literature review were identified using the search engines CINAHL, MEDLINE,
UpToDate, Cochran Database, Academic Search Ultimate, Education Full Text, and Google
Scholar. Search terms included: (vap* or e-cig* or electronic nicotine delivery system* or
electronic vapor products or ENDS) AND (adolescent* or teen*). During the original search,
only articles that were published within the last five years (2014-2019) and in the English
language were included. Articles used for references were chosen based on relatability to ecigarette use in the adolescent population. Due to a limited number of studies that address only
e-cigarette prevention and cessation in the adolescent population, the findings of studies that
generalized e-cigarette use into broader categories of tobacco use or smoking in adolescents were
also included. The author used references from the articles yielded in the original search to
locate alternative articles with significant findings. Information from the collection of articles
was then analyzed and reported in the literature review section of this paper.
Creation of the Education Module
The overall purpose of the module is to train healthcare providers about e-cigarette use in
the adolescent population and give providers the tools needed to diagnose and treat adolescent e-
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cigarette use appropriately. It was decided that this goal would be best achieved by including a
1) thorough background of the history and anatomy of e-cigarettes; 2) why e-cigarette use is
common among teens; 3) what health effects occur in teens as a result of e-cigarette use; 4) what
steps have been taken federally to decrease teen e-cigarette use; 5) the most effective methods of
teen e-cigarette use prevention; and 5) current recommendations on treatment of adolescent
nicotine use specific to e-cigarettes. The most recent and relevant information regarding these
aspects of teenage e-cigarette use was chosen from the literature review to be included in the
presentation.
The education module was initially created using Microsoft PowerPoint. The
presentation was then converted into an interactive module format using the program Adobe
Captivate®. A script was written, edited by members of the committee, and then rewritten and
revised. A voice-over was added to the module and graphics were developed and included.
Pictures were identified by using the “labeled for reuse” feature of Google Images so as not to
include any copyrighted material. The piloted module was approximately 60 minutes in length
as requested by the American Association of Nurse Practitioners (AANP).
Participants
Participants were asked to complete and critique the first draft of the education module.
Participants were recruited using snowball sampling and were not given any form of financial or
other compensation. To be eligible, the participant needed to be an actively practicing nurse
practitioner. All nurse practitioner specialties were eligible to participate (i.e. FNP, PNP, ACNP,
etc.).
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Evaluation of Module Effectiveness
In order to evaluate the effectiveness of the module, participants answered a series of 12
questions about e-cigarette use in the adolescent population before and after viewing the module
(see Appendix A). These questions were developed using specific learning objectives which
included: 1) being able to differentiate between various types of electronic cigarettes; 2) state
multiple vulnerabilities of the adolescent population in regard to e-cigarette use; 3) identify
adverse health effects associated with vaping; 4) correctly educate pediatric patients and their
parents about vaping; 5) use the “5 A’s method” to screen for, prevent, and treat teenage nicotine
use disorder; and 6) understand behavioral and pharmacological treatments for adolescents who
vape. Questions were also asked about the demographics of the participants, including age,
gender, education, and employment (see Appendix A). Lastly, participants were asked one
open-ended question about suggestions for module improvement.
After completing the module, participants were asked the same 12 questions addressing
the learning objectives of the module, and individuals’ post-test scores were compared to their
pre-test scores to assess improvement. Participants’ feedback was also analyzed, and three
themes were generated from the results.
Outcome
The following education module: “An Evidence-Based Approach to Understanding and
Treating Electronic Cigarette Use in the Adolescent Population.”
Link: E-Cig Module
Results
The first draft of the module was piloted by a convenience sample of 12 nurse
practitioners. Of the 12 participants, two identified as being age 30-40, two were age 40-50, six
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were age 50-60, and two were age 60-70. Eleven of the participants were female and one was
male. Four of the participants indicated their highest level of education was a master’s degree
and eight indicated their highest level of education was a doctorate degree. Five participants
noted that they worked primarily in outpatient healthcare, one in inpatient healthcare, one in
primary care, one in residential healthcare, and three in nursing academia.
The effectiveness of the piloted module was measured using the participant’s responses
to 12 questions before and after completing the module: “An Evidence-Based Approach to
Understanding and Treating Electronic Cigarette Use in the Adolescent Population.” The
purpose of the pre- and post-testing was to answer the questions: “By how much does a nurse
practitioner’s general understanding of electronic cigarette use in the adolescent population
improve after completion of the module?”; “By how much does a nurse practitioner’s
understanding of treatment for adolescent nicotine cessation improve after completion of the
module?” ; and, “In what ways can the module be improved?”
Before viewing the educational module, the average test score was 4.6 correct responses
out of 10. After viewing the module, participants answered an average of 7.7 questions correctly
out of 10. Post-test participant scores improved on average by 30.8% or by 3.08 more correctly
answered questions. The difference between the participants’ knowledge before and after
completing the module was significant (t(11)=5.4, p=0.001). Of the 12 participants, 83%
indicated that their general understanding of e-cigarette use in the adolescent population
improved and 83% indicated that their understanding of available treatment options for
adolescent nicotine cessation improved.
Furthermore, nine of the participants provided extensive feedback on how different
aspects of the module could be improved. First, five of the 12 participants noted that the pilot
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module was too long. Second, three participants remarked that they would like the presentation
to be more engaging. For example, one participant said, “(the module) was a little boring to just
listen to.” Another participant suggested, “having words appear on the screen line by line as the
narrator is saying them” to keep listeners engaged. Third, two participants commented that the
presentation slides included too much text and should highlight only the most important points.
One participant suggested that the script be added to the paper as an Appendix, but this feedback
was disregarded because the information for the script is very similar to the information included
in the literature review.
Final Updates to Module
As a result of the participants’ feedback, the module was updated and re-recorded. First,
the content of the piloted module was carefully reviewed and updated to ensure all content
specifically aligned with the learning outcomes. Second, the author updated the module to have
words appear line by line in tandem with the voice of the narrator. Third, the author reduced the
amount of text present on each slide and only included headings and summaries of information
as suggested by participants. The module was then updated with the necessary changes and rerecorded but modified to 50 minutes in length. Once complete, the finalized module was shared
with AANP, as per AANP’s request, to be used as a continuing education module for nurse
practitioners.
Discussion
This project resulted in the development of an online module for nurse practitioners about
adolescent e-cigarette use. Although the sample size was relatively small, reviewers indicated
that they were better prepared to educate their adolescent patients about e-cigarette use, as well
as screen for and treat nicotine dependence in this population, after completing the module.
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These results are consistent with those found in a 2014 systematic review exploring effectiveness
of e-learning in pharmacy education (Salter et al., 2014). This systematic review reported on 11
different studies that applied e-learning in pharmacy, and then measured improvement of
knowledge using pre and post intervention tests. E-learning significantly improved participants’
understanding of educational material in all 11 studies.
Online continuing education learning modules are commonly used for nurse practitioners
to stay up-to-date on the latest evidence. E-learning allows flexibility and is a cost-effective
approach to continuing education (Rostad, Grov, & Moen, 2014). While e-learning is generally
well-received, the effects of e-learning on caregiver practice are difficult to measure (Sinclair et
al., 2015).
This project was unique because it focused specifically on improving nurse practitioners’
understanding of e-cigarette use in the adolescent population. After viewing the module,
participants’ tests scores improved, indicating that their understanding of e-cigarettes improved.
However, none of the participants were able to answer all of the questions correctly, revealing
that effectiveness of the module could be enhanced. Lastly, while the use of e-learning
significantly improved knowledge of subject matter in this and other studies, no studies to date
have been able to measure the long-term effectiveness of e-learning on clinical practice (Salter et
al., 2014). Additional follow-up is needed to determine if this module about e-cigarette use in
adolescents changes nurse practitioners’ practice and subsequent patient outcomes (Rouleau et
al., 2019).
Limitations
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Limitations of this study included a small sample size, absence of random sampling, and
a lack of diversity in the studied population. Because of these factors, this study may not be
generalizable to all populations.
Future Research
Further development of this project should include measuring the long-term effects of the
provided education on nurse practitioners’ practice. Additional research is needed to discover
which formats or aspects of e-learning are the most effective at changing clinician practice.
Conclusion
The purpose of this module was to educate nurse practitioners on the subject of ecigarettes and their effects on adolescent health, as well as provide treatment guidelines for
nicotine dependence in teens who vape. Education was provided in the form of an internetbased, e-learning module addressing these subjects in detail. Effectiveness of the module was
measured using results of a pre and post-intervention test completed by 12 nurse practitioners.
Test scores improved significantly after viewing the module, and 83% of participants selfreported that their understanding of e-cigarette use in the teenage population improved after
completing the module. Clinicians are more likely to screen for and educate their pediatric
patients about vaping when their own understanding of e-cigarettes is improved. Thus, this
module can be used to help nurse practitioners counter the ever-rising number of teens who vape
by improving their understanding of e-cigarette use in the adolescent population.
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Appendix A
Questionnaire for Pre and Post-Test
1. How many high school and middle school aged teens currently use e-cigarettes nationally?
a) 1 in 4 high school students and 1 in 10 middle school students
b) 1 in 6 high school students and 1 in 12 middle school students
c) 1 in 10 high school students and 1 in 15 middle school students
d) 1 in 5 high school students and 1 in 6 middle school students
2. JUUL products always contain nicotine. True or False.
a) True
b) False
3. JUUL and related products are different from typical e-cigarettes because they…
(Choose all that apply)
a) Contain less nicotine per puff than typical e-cigarettes and are generally safer to use
b) Contain only flavorings and water vapor
c) Are shaped like USB sticks and are easy to use discreetly
d) Contain nicotine salts which are more potent than the freebase nicotine contained in
most e-cigarette products
4. Which statement is correct concerning e-liquids?
a) There are approximately 100 different flavor options available for purchase
b) Around 50% of e-liquids on the market contain nicotine
c) Although ingredient lists are not usually included, the labelled nicotine amount is almost
always consistent with the measured amount
d) Many of the ingredients used in e-liquids are deemed safe for consumption by the FDA,
but not safe for inhalation
5. Which answer is FALSE concerning teenage vulnerabilities to e-cigarette use
a) Most teens think that the vapor in e-cigarettes is just water and flavoring
b) Most teens acquire their e-cigarettes from vape shops in their neighborhood
c) Curiosity and peer pressure are big reasons why teens try vaping for the first time
d) E-cigarettes are cheaper to use than conventional cigarettes in the long run
6. Which answer is FALSE concerning how aggressive use of nicotine affects an adolescent’s
brain?
a) Nicotine use in adolescence can cause lifelong incidence of depression, anxiety, and
impulsivity
b) Nicotine use can lead to lifelong addiction and increase affinity for other drugs including
classic cigarettes
c) Although e-cigarettes can damage adolescent brain function, nicotine in and of itself does
not negatively affect the teenage brain
d) Vaping e-liquids that contain nicotine can produce e-cigarette specific withdrawal symptoms
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7. What is the additive responsible for the majority of cases of e-cigarette or vaping-use
associated lung injury (EVALI)?
a) Sorbitol
b) Artificial coloring
c) Vitamin E acetate
d) EDTA
8. What does the “5 A’s” interventional approach include?
a) Assume, Act, Acknowledge, Articulate, Apply
b) Advise, Acknowledge, Act, Apply, Accountable
c) Ask, Advise, Assess, Assist, Arrange follow-up
d) Ask, Acknowledge, Advise, Act, Arrange follow-up
9. Your 15-year-old male patient just admitted to you that he currently uses e-cigarettes and
would like help to quit. Which intervention would be LEAST appropriate?
a) Develop a quit plan with the patient and discuss triggers, barriers, positive influences, coping
strategies and useful resources
b) Refer the patient to a behavioral change program
c) Prescribe medications such as Bupropion and Chantix to aid with cessation attempts
d) Prescribe nicotine patches or nicotine gum to help attenuate withdrawal symptoms
10. Which treatments are currently FDA approved for tobacco cessation in adolescent patients
(under the age of 18)?
a) Nicotine replacement therapies
b) Bupropion
c) Chantix
d) None of the above
11. How would you rate your general understanding of electronic cigarette use in the adolescent
population?
a) Poor
b) Fair
c) Good
d) Very good
12. How would you rate your understanding of available treatment options for adolescent
nicotine cessation?
a) Poor
b) Fair
c) Good
d) Very good
13. About you: How old are you?
14. About you: What is your gender?

ELECTRONIC CIGARETTE USE IN ADOLESCENT POPULATION
15. About you: What is your highest degree?
16. About you: Where do you work?
17. What feedback do you have about the module?
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